Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;34(1):50.
doi: 10.4103/0971-5851.113436.

Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: Clarity needed

Swaroop Revannasiddaiah  1 , Madhup Rastogi, Manoj Gupta, Rajeev Seam
Affiliations

Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: Clarity needed

Swaroop Revannasiddaiah et al. Indian J Med Paediatr Oncol. 2013 Jan.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Roy S, Devleena, Maji T, Chaudhuri P, Lahiri D, Biswas J. Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study. Indian J Med Paediatr Oncol. 2011;32:133–8. - PMC - PubMed
    1. Lanciano R, Martz K, Coia L. Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys. 1991;20:95–100. - PubMed
    1. Narayan K, Fisher RJ, Bernshaw D. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent. Int J Gynecol Cancer. 2008;18:525–33. - PubMed
    1. Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, et al. Lymph node staging by positron emission tomography in cervical cancer: Relationship to prognosis. J Clin Oncol. 2010;28:2108–13. - PubMed
    1. Wolfson AH, Abdel-Wahab M, Markoe AM, Raub WJ, Jr, Diaz D, Desmond JJ, et al. A quantitative assessment of standard vs. customized midline shield construction for invasive cervical carcinoma. Int J Radiat Oncol Biol Phys. 1997;37:237–42. - PubMed